News & Resources

Activation Capital integrates entrepreneurship programs with strategic space-making to optimize the translation and value of regional life science discoveries, driving growth in pharmaceuticals, biotech, and medical devices.
Activation Capital celebrates the successful closeout of a GO Virginia grant, which laid the foundation for Central Virginia's emergence as a hub for advanced pharmaceutical manufacturing, driving growth in infrastructure, workforce, and supply chain development.
The pharmaceutical and medical technology sectors face a critical challenge: a significant reliance on overseas production for key ingredients and chemical starting materials with insufficient capacity and economic incentive for domestic production.
New biohealth pre-accelerator program offers early-stage biotech founders’ essential skills and guidance to prepare for advanced stages, fostering innovation in the growing life sciences sector.
Ten innovative life sciences and healthtech companies enter 16-week accelerator.
The Virginia Biotechnology Research Park Authority Board appointed Robert Ward as interim president and chief executive officer of Activation Capital, an innovation ecosystem development organization, effective today.
Activation Capital, an innovation ecosystem development organization, announced today that Chandra Briggman, president and chief executive officer of Activation Capital, will depart the organization to pursue new opportunities to build innovation ecosystems and drive economic development.  
Activation Capital launches Frontier BioHealth, an educational and support program offering training, targeted mentorship, and relationship building to help scale pharmaceutical, biotech, medical device, and health-focused consumer products companies.
Activation Capital, an innovation ecosystem development organization, announced today that it has appointed Jim Pannucci, Ph.D., PMP as its Vice President of Entrepreneurship.
The U.S. National Science Foundation has announced that the public and private sector stakeholders in the Richmond-Petersburg region, working together as the Alliance for Building Better Medicine, will receive one of the first-ever NSF Regional Innovation Engines (NSF Engines) Development Awards (Type 2) including $1M in funding. NSF Engines represent one of the single largest broad investments in place-based research